Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

Aspiration pneumonitis (Disease Or Phenotype)

Nci:C34932

Mondo:MONDO:2572

Mdr:MDR:10035744

Id:7570e163-7aad-5e14-ac1e-00ac63f2f272

Efo:EFO:1001399

Results found

Linked to

	Label	Description
	methylprednisolone indication Aspiration pneumonitis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Hydrocortisone hemisuccinate indication Aspiration pneumonitis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	triamcinolone indication Aspiration pneumonitis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Triamcinolone diacetate indication Aspiration pneumonitis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Hydrocortisone indication Aspiration pneumonitis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	betamethasone indication Aspiration pneumonitis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Betamethasone acetate indication Aspiration pneumonitis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	prednisolone indication Aspiration pneumonitis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Acetic acid 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester indication Aspiration pneumonitis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Triamcinolone Acetonide indication Aspiration pneumonitis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

methylprednisolone indication Aspiration pneumonitis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Hydrocortisone hemisuccinate indication Aspiration pneumonitis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

triamcinolone indication Aspiration pneumonitis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Triamcinolone diacetate indication Aspiration pneumonitis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Hydrocortisone indication Aspiration pneumonitis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

betamethasone indication Aspiration pneumonitis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Betamethasone acetate indication Aspiration pneumonitis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

prednisolone indication Aspiration pneumonitis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Acetic acid 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester indication Aspiration pneumonitis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Triamcinolone Acetonide indication Aspiration pneumonitis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.